TD Asset Management
NERV icon

TD Asset Management’s Minerva Neurosciences NERV Stock Holding History

TD Asset Management’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,156
Closed -$200K – 1392
2020
Q1 		$200K Sell
4,156
-1,975
-32% -$119K ﹤0.01% 1316
2019
Q4 		$349K Sell
6,131
-150
-2% -$6.62K ﹤0.01% 1298
2019
Q3 		$389K Sell
6,281
-1,075
-15% -$60.9K ﹤0.01% 1215
2019
Q2 		$331K Buy
7,356
+200
+3% +$10K ﹤0.01% 1234
2019
Q1 		$450K Buy
7,156
+707
+11% +$42.5K ﹤0.01% 1199
2018
Q4 		$348K Buy
6,449
+187
+3% +$13.7K ﹤0.01% 1286
2018
Q3 		$629K Buy
6,262
+38
+0.6% +$2.86K ﹤0.01% 1248
2018
Q2 		$411K Hold
6,224
– – ﹤0.01% 1301
2018
Q1 		$311K Hold
6,224
– – ﹤0.01% 1275
2017
Q4 		$301K Sell
6,224
-38
-0.6% -$1.88K ﹤0.01% 1264
2017
Q3 		$381K Sell
6,262
-1,325
-17% -$76K ﹤0.01% 1201
2017
Q2 		$537K Buy
7,587
+4,199
+124% +$272K ﹤0.01% 1173
2017
Q1 		$220K Buy
3,388
+45
+1% +$3.5K ﹤0.01% 1361
2016
Q4 		$314K Sell
3,343
-129
-4% -$13.2K ﹤0.01% 1287
2016
Q3 		$392K Buy
+3,472
New +$337K ﹤0.01% 1243

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TD Asset Management's NERV Position: Q2 2020 in Review

TD Asset Management sold out of Minerva Neurosciences (NERV) in Q2 2020, closing a stake of 4,156 shares — an estimated $200K sold.

TD Asset Management first reported a position in NERV in Q3 2016 and held it in 15 quarters. The position peaked at $629K in Q3 2018. 80 funds tracked by Wall St. Rank hold NERV as of Q2 2020.

  • TD Asset Management reported no remaining Minerva Neurosciences position as of Q2 2020 after selling out during the quarter.
  • TD Asset Management sold 4,156 Minerva Neurosciences shares in Q2 2020, an estimated $200K.
  • TD Asset Management first reported a position in Minerva Neurosciences in Q3 2016 and held it in 15 quarters.
  • TD Asset Management's Minerva Neurosciences position peaked at $629K in Q3 2018.
  • 80 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2020.

Based on TD Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.